Heron Therapeutics, Inc.

US$0.29As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:HRTXHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (32.41%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 1.65
PE TTM —
TSR TTM (74.74%)
Mkt cap US$55.63M
ROIC (4.46%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.325
11.02%
(1.72%)
Hold 5|3|9|9|6
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
11.17%
16.75%
23.74%
17.06%
Revenue$M
5.062
5.293
5.554
5.582
7.41%
8.25%
12.02%
12.88%
Peers (US$55.63M)
Cap (US$)
PE
56.15M
—
Capital
TTM
5Y
10Y
Leveragex
0.866
0.075
0.074
EBIT/Intx
0.395
0.138
0.136
Own earn%
(2.61)
(19.52)
(17.22)
Sh yield%
49.74
35.70
34.41
Owners
Insiders/Inst%
11.31
49.97
Short interest%
2.54
SBC / revenue%
1.60
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
24–28
$1 testx
—
Incr. ROIC%
9